Kristina Burow
ARCH Venture Partners Managing Director
investment range
$50k - $150.0m
sweet spot
$50k
Kristina Burow's Past Investments (9)
| Company | Deal Type | Amount | Date | |
|---|---|---|---|---|
| Erasca | Series A | $22M (Lead) | Mar 2019 | |
| Gossamer Bio | Series A | $100M (Lead) | Jan 2018 | |
| Vividion Therapeutics | Series A | $50M (Lead) | Feb 2017 | |
| Vir Biotechnology | Venture Round | $150M (Lead) | Jan 2017 | |
| Receptos | Series B | $30M | Mar 2013 | |
| Receptos | Venture Round | $30M | Mar 2012 | |
| Kilimanjaro Energy | Series A | $2.3M (Lead) | Aug 2010 | |
| Receptos | Series A | $25M | Nov 2009 | |
| Lycera | Series A | $36M (Lead) | May 2009 |
Kristina Burow's Experience
Managing Director ARCH Venture Partners2002 - Present
Kristina Burow's Education
University of California, Berkeley
The University of Chicago Booth School of Business MBA
Kristina Burow's Media
No media found for Kristina Burow.